- Home
- FRGT vs XRTX Comparison
FRGT vs XRTX Comparison
Compare FRGT & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- XRTX
- Stock Information
- Founded
- FRGT 2015
- XRTX 2011
- Country
- FRGT United States
- XRTX Canada
- Employees
- FRGT N/A
- XRTX N/A
- Industry
- FRGT Professional Services
- XRTX Pharmaceuticals and Biotechnology
- Sector
- FRGT Consumer Discretionary
- XRTX Health Care
- Exchange
- FRGT Nasdaq
- XRTX Nasdaq
- Market Cap
- FRGT 2.1M
- XRTX 3.0M
- IPO Year
- FRGT N/A
- XRTX N/A
- Fundamental
- Price
- FRGT $0.96
- XRTX $0.91
- Analyst Decision
- FRGT
- XRTX
- Analyst Count
- FRGT 0
- XRTX 0
- Target Price
- FRGT N/A
- XRTX N/A
- AVG Volume (30 Days)
- FRGT 256.1K
- XRTX 16.8K
- Earning Date
- FRGT 05-08-2025
- XRTX 05-16-2025
- Dividend Yield
- FRGT N/A
- XRTX N/A
- EPS Growth
- FRGT N/A
- XRTX N/A
- EPS
- FRGT N/A
- XRTX N/A
- Revenue
- FRGT $17,567,033.00
- XRTX N/A
- Revenue This Year
- FRGT $144.53
- XRTX N/A
- Revenue Next Year
- FRGT $55.01
- XRTX N/A
- P/E Ratio
- FRGT N/A
- XRTX N/A
- Revenue Growth
- FRGT N/A
- XRTX N/A
- 52 Week Low
- FRGT $0.93
- XRTX $0.82
- 52 Week High
- FRGT $42.50
- XRTX $3.92
- Technical
- Relative Strength Index (RSI)
- FRGT 34.76
- XRTX 47.79
- Support Level
- FRGT $0.93
- XRTX $0.91
- Resistance Level
- FRGT $1.30
- XRTX $1.10
- Average True Range (ATR)
- FRGT 0.10
- XRTX 0.08
- MACD
- FRGT -0.04
- XRTX -0.00
- Stochastic Oscillator
- FRGT 4.76
- XRTX 34.21
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.